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10550 North Torrey Pines Road, La Jolla, California 92037Received July 17, 2000; accepted July 27, 2000Following infection, a virus must battle against the
host’s immune response. Viruses which cause persistent
infections are obliged to subvert the immune system in
order to prevent being recognized and eliminated by the
host’s immune response. Acute viral infections, on the
other hand, may slow or temporarily hamper the immune
response in order to maximize their replication and
transmission, but either they are eliminated by the host
or they eliminate the host. Viral interference with the
immune response is termed either immune evasion or
immunosuppression. Immune evasion prevents an effec-
tive immune response to the initiating virus and is gen-
erally of benefit to the pathogen. Generalized immuno-
suppression, however, inhibits or depresses the immune
response toward itself as well as toward unrelated
pathogens. Examples of viral immune evasion include
mechanisms such as latency, downregulation of immune
regulatory proteins, and viral mimicry of host immune
regulatory proteins. These mechanisms are extensively
reviewed elsewhere and will not be discussed further
here.
Although many viral infections display immune eva-
sion strategies, few cause generalized immunodefi-
ciency. This is in contrast to parasitic infections which
quite often lead to depression of the immune response.
The mechanisms of parasitic modulation of the immune
response are quite varied and include cytokine and cy-
tokine receptor modulation. It is believed that there is a
more limited repertoire of mechanisms involved in virus-
induced immunosuppression, including dysregulation of
early cytokine production and destruction of antigen-
presenting cells (APC), T lymphocytes, or bone marrow
progenitor cells.
This review will focus on the mechanisms involved in
the three main human viral infections causing immuno-
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227suppression: measles (MV), human immunodeficiency
virus (HIV), and cytomegalovirus (CMV). We will also
discuss what has been learned from the extensively
studied mouse models of viral-induced immunosuppres-
sion: lymphocytic choriomeningitis virus (LCMV) and
Rauscher leukemia virus (RLV).
The viruses inducing generalized immunosuppression
appear to use very similar mechanisms. By parallel strat-
egies, they hinder antigen presentation to T cells and/or
disrupt hematopoiesis. To discuss the specific pathways
involved, we will briefly introduce these immunological
targets of virus-induced immunosuppression.
Disruption of APC function (dendritic cells or macro-
phages) is a favored mechanism for viruses in their
quest to suppress the immune response. Dendritic cells
(DC) are believed to trigger the entire immune response.
They phagocytose foreign antigens and upon activation
migrate to secondary lymphoid organs such as the
spleen and draining lymph nodes where they can stim-
ulate specific T cells. These activated DC as well as
macrophages then produce the cytokines interferon-a/b
type I (IFN-a/b) and interleukin-12 (IL-12) which orches-
trate a cascade of reactions that contribute to the gen-
eration of an antiviral T cell response (Fig. 1).
Viruses have also been described to interfere with the
early events of T cell activation which determine whether
a type 1 (Th1) or type 2 (Th2) effector T cell will be
generated. The classification into type 1 and type 2
effectors is based on the observed differential ability of T
cells to secrete certain cytokines. The Th1 cytokines,
represented by IFN-g and IL-2, favor vigorous cytotoxic T
cell responses. The Th2 cytokines IL-4, IL-5, and IL-10
diminish the cellular immune response and favor the
antibody response (Fig. 1). Skewing the immune re-
sponse toward Th2 is believed to favor immunosuppres-
sion. This was first described for the parasite Leishmania
major and has since been extended to many other par-
asites and a few viruses (Heinzel et al., 1989).Finally, hematopoiesis, which gives rise to most of the
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228 MINIREVIEWeffector cells of the immune system, represents a poten-
tial target for immunosuppressive viruses. The primitive
pluripotent stem cells of the bone marrow divide to
produce committed progenitor cells of the lymphoid, my-
eloid, megakaryocyte, and erythroid lineages. T and B
lymphocytes derive from the lymphoid progenitor cells,
whereas macrophages originate from the myeloid pro-
genitors. DC descend from both the myeloid and lym-
phoid lineages (Fig. 1). Viruses that infect bone marrow
cells can selectively disrupt particular hematopoietic lin-
eages by targeting specific differentiation states of the
progenitor cells.
The lymphocytic choriomeningitis virus (LCMV) and
Rauscher leukemia virus (RLV) animal models were the
first to suggest dendritic cell dysfunction or destruction
as a mechanism of immunosuppression. A variant of the
LCMV Armstrong strain, clone 13 causes persistent in-
fection accompanied by a generalized immunosuppres-
sion in the adult mouse (Ahmed et al., 1984). Mice per-
istently infected with LCMV clone 13 are unable to
ount effective immune responses to other viruses
Roost et al., 1988; Tishon et al., 1993) or to parasites
Wu-Hsieh et al., 1988). During progression of an LCMV
lone 13 infection, the dendritic cells of the splenic white
ulp become preferential targets of LCMV and their sub-
equent destruction prevents initiation of an immune
esponse to other pathogens (Borrow et al., 1995). LCMV
clone 13 infection does not result in lifelong persistence
and a low-level immune response progresses slowly,
eventually clearing the virus. It is likely that during the
FIG. 1. Schematic diagram of the events taking place after dendritic
DC migrates to lymph nodes where it secretes large quantities of IFN
response. A type 1 response will lead to T-helper cell (Th) secretion of
may cause a type 2 response to be favored. This leads to secretion of
have an inhibitory effect on type 1 cytokine secretion. These pathwa
response. The passage of T cells through the thymus is not shown.persistent phase, LCMV infection leads to destruction ofsplenic DC and newly differentiated DC as they are
regenerated from bone marrow. When virus is cleared,
the immune response to other pathogens is restored.
The return of the immune response to a normal state
after disappearance of the virus argues for a peripheral
effect on APC generation rather than a more profound
effect of LCMV on hematopoiesis.
The murine model of RLV infection, similarly to the
LCMV model, has shown that disruption of DC function
underlies immunosuppression. RLV is a retrovirus that
causes acute pathological effects accompanied by im-
munosuppression and tumors which are rapidly lethal
(Gabrilovich et al., 1994a). RLV infects peripheral DC in
vivo, thereby reducing their ability to migrate from their
resident tissue to lymph nodes after stimulation with a
contact sensitizer (Gabrilovich et al., 1994b). RLV can
also infect dendritic cell progenitors in the bone marrow
and the subsequently differentiated DC are inhibited in
their ability to produce IL-12. Although only 20% of the
bone marrow-derived DC from RLV-infected mice are
infected, a slight imbalance of IL-12 production may be
sufficient to engender a cycle of decreased DC genera-
tion and function. Administration of IL-12 at the time of
infection restores the ability of bone marrow DC to stim-
ulate allogeneic T cells and also reverses the RLV-in-
duced defect in peripheral DC migration (Kelleher et al.,
1999; Williams et al., 1998).
Both of these murine models have illustrated the im-
portance of DC and/or IL-12 in triggering an effective
antiviral cellular immune response, as well as demon-
C) activation. The hematopoietic origin of the cells is also shown. The
nd IL-12, thus driving the immune response toward a type 1 cellular
d IFN-g as well as cytotoxic T cell activity. A lack of IL-12 and IFN-a/b
d IL-10 and to a strong humoral antibody response. IL-4 and IL-10 will
esent potential targets for virus-induced suppression of the immunecell (D
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229MINIREVIEWDC and RLV by preventing their migration and inhibiting
IL-12 synthesis.
Measles virus infection was the first human virus to be
recognized as being clinically immunosuppressive (Von
Pirquet, 1908). MV-induced transient immunosuppres-
sion can last up to 6 months after acute measles infec-
tion and has frequently been associated with high mor-
bidity and mortality. Measles presents the interesting
and unique case of inducing a prolonged immunosup-
pression present for months following the infection when
there is no detectable virus present.
Measles virus infection of lymphocytes renders them
nonresponsive to mitogenic or antigenic stimulation in
vitro. This has been shown to be due to a G-0-like block
in the cell cycle occurring in the presence of partial
activation of the lymphocytes (McChesney et al., 1987,
1988; Naniche et al., 1999). MV-infected cells can also
rrest the proliferation of uninfected cells by direct con-
act (Schlender et al., 1996). This is believed to be me-
iated by the MV fusion protein expressed on the surface
f infected cells (Weidmann et al., 2000). Thus, MV fusion
rotein and possibly other MV proteins can have a direct
mmunosuppressive activity.
In addition to disrupted lymphocyte function, APC
unction itself has recently been shown to be depressed
n vitro. MV infection of DC not only abolishes their ability
o present antigen to T cells but also promotes cell death
f T lymphocytes by apoptosis (Fugier-Vivier et al., 1997;
rosjean et al., 1997; Schnorr et al., 1997). MV-infected
DC and monocytes, similarly to RLV-infected murine DC,
are impaired in their ability to produce the cytokine IL-12
(Karp et al., 1996). In addition, wild-type virulent strains of
MV have the capacity to inhibit IFN-a/b production in
itro (Naniche et al., 2000). By inhibiting both IL-12 and
FN-a/b, MV may have established a strategy to slow the
evelopment of the early immune response and thus
ncrease viral spread and pathogenesis. As measles
rogresses, the levels of Th1 cytokines (IFN-g and IL-2)
ecrease and give way to a rise in IL-4 levels which is
ustained for several months (Griffin and Ward, 1993;
riffin et al., 1990). A predominance of a Th2 (IL-4, IL-5,
L-10) response has been suggested to contribute to
ong-term immunosuppression in measles patients.
easles infection may preferentially kill or activate cer-
ain subtypes of DC responsible for eliciting a Th1 re-
ponse while skewing the response to favor Th2.
In cases of measles-induced immunosuppression
asting up to 6 months in the absence of virus replication,
more profound depletion of bone marrow progenitor
ells during acute infection could account for a delay in
he recovery of the immune system. It has been shown in
hesus macaque and cynologous monkey models of
easles that the bone marrow is infected and contains
igh titers of virus (Kobune et al., 1996; McChesney et al.,
1997). A recent report has also shown productive in vitro
infection of human bone marrow myeloid granulocyte–macrophage colony-forming cells (CFC-GM) (Helin et al.,
1999). MV infection can reach the bone marrow in hu-
mans as illustrated by analyses of patients suffering from
Paget’s disease, characterized by disordered bone for-
mation due to abnormal osteoclast bone resorption. The
presence of paramyxoviruses including measles has
been demonstrated in bone marrow from Pagetic pa-
tients (Mee et al., 1998; Mills et al., 1994; Reddy et al.,
1996).
Since the rhesus macaque model suggests that a high
number of infected cells are likely to be present in lymph
nodes during acute measles, early events of immuno-
suppression may be due to mechanisms such as pertur-
bation of function by direct infection, cell cycle block of
infected T lymphocytes, apoptosis of uninfected T lym-
phocytes by MV-infected DC, or inhibition of IL-12 and/or
IFN-a/b synthesis. However, the long-term suppression
that persists in the absence of detectable virus may be
due to profound effects on bone marrow progenitor cell
growth and differentiation.
HIV isolated only two decades ago is responsible for a
severe immunosuppression which progresses slowly,
providing an increasingly favorable terrain for opportu-
nistic infections and reactivation of latent infections. It is
well documented that T lymphocytes expressing the CD4
molecule are the main targets of HIV infection and their
declining numbers in the peripheral blood reflect the
progression of AIDS. Although CD4 T lymphocytes are
important players in the immune response, their destruc-
tion is not believed to be the only cause of immunosup-
pression. HIV infection also results in APC defects that
could explain the loss of CD4 responses early in HIV
infection when T cell numbers are still within the normal
range.
HIV, similarly to measles, can infect professional anti-
gen-presenting DC and impair their capacity to stimulate
T cells in vitro. This effect depends on the stage of
differentiation of a DC, as DC induced to mature and
differentiate in vitro can be infected by HIV but their
antigen-presenting function is not impaired (Knight et al.,
1997). During HIV progression in humans, DC numbers
are reduced in the peripheral blood of HIV patients (Ma-
catonia et al., 1990). Since DC, which express high levels
of class II, have been shown to contribute to the main-
tenance of CD4 T lymphocytes (Brocker, 1997), a de-
crease in functional DC could lead to death of the CD4 T
lymphocytes.
Impaired APC function cannot solely account for the
observed progressive immunosuppression due to HIV
since bone marrow stem cells should continuously re-
generate peripheral APC. Contrary to potential MV ef-
fects on bone marrow which persist after clearance of
acute infection, HIV effects stem from a chronic infection
and over the course of AIDS disease there is a progres-
sive loss of the capacity to generate functional DC from
bone marrow progenitor cells (Knight et al., 1995; Ma-
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230 MINIREVIEWrandin et al., 1996; Re et al., 1994). There are conflicting
eports as to the capacity of HIV to directly infect bone
arrow progenitor cells (reviewed in Moses et al., 1998).
umerous studies have shown that the primitive CD341
D332 hematopoietic stem cells from HIV-1 patients are
ot infected with HIV, nor are they infectable in vitro. As
he bone marrow stromal microenvironment contains
umerous cell types which are essential to the growth of
D341 progenitor cells, HIV infection of support cells
as been suggested to explain the bone marrow sup-
ression (Moses et al., 1998). The stromal cells are a
eterogeneous cell pool consisting of stromal epithelial
ells, microvascular endothelial cells, and macrophages,
hich all contribute to the regulation of cell growth and
ifferentiation of CD341 stem cells. Stromal epithelial
ells appear resistant to HIV infection, whereas micro-
ascular endothelial cells and bone marrow macro-
hages have consistently been shown to be infected by
IV in seropositive patients regardless of the stage of
isease (Moses et al., 1996). The mechanism may work
ia inhibition of growth factors and cytokines essential
or hematopoiesis. This is illustrated by experiments
howing that HIV-infected human stromal cell popula-
ions significantly decrease the ability of human as well
s mouse hematopoietic precursor cells to form colonies
n vitro (Bahner et al., 1997). The progressive worsening
mmunosuppression associated with AIDS may thus
rise from the impairment of dendritic cell, macrophage,
nd/or T cell regeneration due to the infection of bone
arrow auxiliary cells supporting hematopoietic growth.
Additional mechanisms have also been put forth to
xplain HIV-induced immunosuppression. Apoptotic cell
eath has been suggested to generally weaken the im-
une response in HIV-infected patients. CD4 and CD8 T
ymphocytes from HIV-infected patients are extremely
ensitive to Fas-induced apoptosis (Katsikis et al., 1995).
urthermore, when quiescent nonactivated HIV-infected
D4 lymphocytes home to lymph nodes, it has been
hown that signaling through the homing receptor in-
uces apoptosis (Wang et al., 1999). There are also
eports that the envelope protein gp120 and the tat pro-
ein of HIV can have immunosuppressive effects: gp120
inds to uninfected CD4 cells and induces a nonrespon-
ive state by preventing CD4 interaction with the APC,
nd tat is a soluble virus protein that can induce
poptosis in uninfected cells (Cohen et al., 1999; Fidler
nd Rees, 1999; Li et al., 1995). Increased secretion of
ertain Th2 cytokines such as IL-10 has also been sug-
ested to suppress the immune response (Schols and
e Clercq, 1996). Finally, disruption of the lymphoid or-
an architecture by HIV binding to and progressively
estroying the follicular dendritic cell network is believed
o be a mechanism leading to the collapse of the immune
ystem (Tenner-Racz and Racz, 1995; Zhang et al., 1999).
These peripheral events likely all contribute to immu-
osuppression in the early stages when hematopoiesiss occurring properly and maintaining a relatively normal
evel of cellular regeneration. The collapse may arise
hen hematopoiesis falters and can no longer compen-
ate for the other immunologic abnormalities. It is not yet
lear what molecular events lead to the final irreversible
ollapse.
Human cytomegalovirus, a member of the herpesvirus
amily, is another example of a human immunodefi-
iency-inducing virus. Infection of individuals with nor-
al immune responses causes an acute infection ac-
ompanied by transient immunosuppression. The im-
une dysfunctions improve to normal responsiveness
ver a period of weeks or months. The virus then estab-
ishes a latent infection with minor or no symptoms. CMV
s thus different from both MV and HIV in that it is a
ersistent infection which induces a transient immuno-
uppression.
Several mechanisms have been put forward to explain
MV-induced immunosuppression. Early reports sug-
ested that CMV could have a direct inhibitory effect on
ytotoxic T lymphocytes (Schrier et al., 1985; Schrier and
Oldstone, 1986) or on monocyte function (Buchmeier and
Cooper, 1989; Carney and Hirsch, 1981; Rinaldo et al.,
1980). CMV is a strong inducer of IFN-a/b in PBMC.
Recent studies have shown that the in vitro CMV-trig-
gered suppression of monocyte activation is due to the
IFN-a/b produced by these cells leading to suppression
of monocyte functions such as oxidative activity and
phagocytosis (Noraz et al., 1997).
Another hallmark of CMV infection is the suppression
of hematopoiesis in the bone marrow. It has been shown
that while some wild-type field isolates can directly infect
progenitor cells and impair their growth, others can only
infect bone marrow stromal cells. This stromal cell tro-
pism, reminiscent of HIV infection, profoundly inhibits in
vitro progenitor cell colony growth by diminishing the
production of certain growth factors such as G-CSF
(Lagneaux et al., 1994; Simmons et al., 1990).
Therefore, CMV appears to be able to infect primitive
progenitor cells as well as stromal support cells, in
contrast to HIV which only infects auxiliary support cells.
Viral infection of bone marrow may thus be the primary
mechanism of CMV-induced immunosuppression.
MV, HIV, and CMV provide three examples of virus
infections which induce generalized immunosuppres-
sion but have dramatically different outcomes. Theses
viruses act by (1) dysregulating the early IL-12/Th1/Th2
cytokine balance, (2) disabling dendritic cell and/or mac-
rophage function, (3) disrupting hematopoiesis, and (4)
producing immunosuppressive proteins. Viruses which
target hematopoiesis may completely devastate the im-
mune system as seen with HIV or may establish benign
latency as with CMV. The reasons which determine
these dramatically different outcomes are likely to be
due to complex differences in the viral life cycle.Much but not all of the experimental data concerning
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231MINIREVIEWvirally induced immunosuppression has been obtained
in vitro. However, the murine models of LCMV and RLV
nfections have confirmed that similar mechanisms are
t work in vivo. Immunosuppression results not from a
ingle mechanism of immune dysregulation but rather
rom an accumulation of immunological roadblocks that
ay begin minimally and undergo amplification as the
mmune response evolves.
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